| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 2,418 shares
@ $27.2493, valued at
$65.9k
Exercised 2,418 options to buy
@ $11.35, valued at
$27.4k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/22/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 4,588 shares
@ $31.19, valued at
$143.1k
Exercised 3,755 options to buy
@ $8.27, valued at
$31.1k
Exercised 833 options to buy
@ $11.35, valued at
$9.5k
|
|
| 08/09/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 412 shares
@ $31.22, valued at
$12.9k
Exercised 412 options to buy
@ $8.27, valued at
$3.4k
|
|
| 08/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/07/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 10,000 shares
@ $23.6, valued at
$236k
Exercised 10,000 options to buy
@ $11.35, valued at
$113.5k
|
|
| 06/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/05/2023 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,411 shares
@ $22.97, valued at
$32.4k
Granted 1,411 shares
@ $0 |
|
| 02/11/2022 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 100,000 options to buy
@ $19.26, valued at
$1.9M
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 25,000 shares
@ $25.2128, valued at
$630.3k
Exercised 25,000 options to buy
@ $8.27, valued at
$206.8k
|
|
| 02/08/2021 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 100,000 options to buy
@ $29.41, valued at
$2.9M
|
|
| 02/04/2021 |
4
| Lyon Joseph Douglas (Chief Accounting Officer) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Sold 25,000 shares
@ $29.1828, valued at
$729.6k
Exercised 25,000 options to buy
@ $8.27, valued at
$206.8k
|
|
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |